Drug and Diagnostic Shortages

TB Drug and Diagnostic Shortages

APLISOL®

CDC announced that Par Pharmaceuticals estimates a 3-10 month nationwide shortage of APLISOL®, anticipating a supply interruption of 5 mL (50 tests) beginning in June 2019, followed by a supply interruption of 1 mL (10 tests) in November 2019, or earlier, if demand increases before then.